Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Cheesecake Factory
CAKE
$5.33B
| $3.03M | ﹤0.01% |
72,716
-14,997
| -17% | -$617K |
|
2352
CALL
Ambarella
AMBA
$3.81B
| $3.03M | ﹤0.01% |
48,200
-11,200
| -19% | -$581K |
|
2353
Cabot Corp
CBT
$4.52B
| $3.03M | ﹤0.01% |
66,809
-7,808
| -10% | -$337K |
|
2354
Gentex
GNTX
$5.07B
| $3.03M | ﹤0.01% |
109,941
-131,015
| -54% | -$3.46M |
|
2355
Sonoco
SON
$5.74B
| $3.03M | ﹤0.01% |
52,006
-3,762
| -7% | -$224K |
|
2356
Applied Industrial Technologies
AIT
$13.3B
| $3.02M | ﹤0.01% |
53,232
+6,607
| +14% | +$372K |
|
2357
Progress Software
PRGS
$1.76B
| $3.02M | ﹤0.01% |
79,387
+9,220
| +13% | +$370K |
|
2358
CALL
Crown Holdings
CCK
$13.1B
| $3.02M | ﹤0.01% |
45,700
+41,500
| +988% | +$2.66M |
|
|
WNS
2359
DELISTED
WNS Holdings
WNS
| $3.02M | ﹤0.01% |
51,340
+5,345
| +12% | +$326K |
|
|
SEM
2360
DELISTED
Select Medical
SEM
| $3.01M | ﹤0.01% |
337,113
+11,981
| +4% | +$105K |
|
2361
CALL
Global Payments
GPN
$22.8B
| $3M | ﹤0.01% |
18,892
+18,092
| +2,262% | +$2.95M |
|
2362
Boston Beer
SAM
$1.92B
| $3M | ﹤0.01% |
8,241
+1,103
| +15% | +$434K |
|
2363
CALL
AstraZeneca
AZN
$250B
| $3M | ﹤0.01% |
33,600
-82,850
| -71% | -$7.18M |
|
|
BRFS
2364
DELISTED
BRF SA
BRFS
| $2.99M | ﹤0.01% |
326,508
-90,900
| -22% | -$827K |
|
|
AVYA
2365
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.98M | ﹤0.01% |
291,606
-66,487
| -19% | -$781K |
|
2366
Range Resources
RRC
$8.95B
| $2.98M | ﹤0.01% |
780,202
+270,462
| +53% | +$1.3M |
|
|
MRO
2367
CALL
DELISTED
Marathon Oil Corporation
MRO
| $2.98M | ﹤0.01% |
242,800
-193,800
| -44% | -$2.51M |
|
2368
Emergent Biosolutions
EBS
$248M
| $2.98M | ﹤0.01% |
56,960
-6,338
| -10% | -$295K |
|
2369
KBR
KBR
$4.8B
| $2.98M | ﹤0.01% |
121,279
+2,301
| +2% | +$58.4K |
|
2370
Donaldson
DCI
$11.4B
| $2.98M | ﹤0.01% |
57,145
+3,427
| +6% | +$170K |
|
2371
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.45B
| $2.98M | ﹤0.01% |
22,102
-195,815
| -90% | -$27.7M |
|
|
DCH
2372
PUT
Dauch Corp
DCH
$1.51B
| $2.96M | ﹤0.01% |
360,700
+12,300
| +4% | +$112K |
|
2373
Encore Capital Group
ECPG
$2.13B
| $2.96M | ﹤0.01% |
88,874
-96,424
| -52% | -$3.39M |
|
2374
PUT
Helmerich & Payne
HP
$3.71B
| $2.95M | ﹤0.01% |
73,600
+600
| +0.8% | +$26.5K |
|
2375
First Trust Preferred Securities and Income ETF
FPE
$6.36B
| $2.95M | ﹤0.01% |
149,400
| – | – |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.